Ameriprise’s Acceleron Pharma XLRN Stock Holding History

Ameriprise’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,400	Closed	-$757K	–	4107
2021 Q3	$757K	Buy	+4,400	New	+$576K	﹤0.01%	3273

Ameriprise's XLRN Position: Q4 2021 in Review

Ameriprise sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 17,396 shares — an estimated $3M sold.

Ameriprise first reported a position in XLRN in Q4 2014 and held it in 11 quarters. The position peaked at $93.1M in Q3 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Ameriprise reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Ameriprise sold 17,396 Acceleron Pharma shares in Q4 2021, an estimated $3M.
Ameriprise first reported a position in Acceleron Pharma in Q4 2014 and held it in 11 quarters.
Ameriprise's Acceleron Pharma position peaked at $93.1M in Q3 2020.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Ameriprise's 13F filing for Q4 2021, filed 14 Feb 2022.